Global Leader in Drug Name Development
The Global Leader in
Drug Name Development
In the pharmaceutical and biotech industries, a drug’s name is more than just a label—it’s a critical asset. A well-crafted name must be distinctive, memorable, regulatory-compliant, and globally viable. Choosing the right naming agency can mean the difference between a seamless approval process and costly delays.
👉 Schedule your free consultation now!
👉 Schedule your free consultation now!
The Brand Institute Advantage
Industry-Leading Expertise
- 30+ years developing successful brands names.
- 14 consecutive years leading global drug name approvals.
Regulatory Excellence
- Regulatory subsidiary (Drug Safety Institute) with ex-naming-officials from FDA, EMA, Health Canada, etc.
- Co-authored the name review guidelines while with their former, respective agencies.
Proven Success
- Expert creative, trademark and market research services.
- Ongoing support with no hidden fees.

Our Regulatory Advantage
Former Naming Officials
- Former FDA, EMA, Health Canada, AMA, and WHO naming leaders personally involved in every project.
Fully Compliant Methodology
- Continuously updated per global health agency guidance and leadership interactions.
Tiered Name Recommendations
- Regulatory-based safety research helps teams balance risk and commercial appeal.
Why Choose Brand Institute?
- Our people, our process, and a proven track record of exceptional results.
- Partnered with over 1,500 on over 5,000 healthcare-related names.
- Expertise in all disciplines required to bring a great brand to market.